Cited In for PMID: 39578732

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2024	1
2025	2

Results by year

Page 1

The most effective combination of pharmacological therapy for heart failure with reduced ejection fraction: a network meta-analysis of randomized controlled trials.

Tang H, Germinal K, Milfort A, Chen WH, Chang SH, Huang W, Li Y, Lu Y, Ahmed MM, Kimmel SE, Bian J, Guo J. Tang H, et al. BMC Cardiovasc Disord. 2024 Nov 23;24(1):666. doi: 10.1186/s12872-024-04339-3. BMC Cardiovasc Disord. 2024. PMID: 39578732 Free PMC article.

Eligibility of Outpatients with Chronic Heart Failure for Vericiguat and Omecamtiv Mecarbil: From Clinical Trials to the Real-World Practice.

Basile P, Falagario A, Carella MC, Dicorato MM, Monitillo F, Santoro D, Naccarati ML, Pontone G, Ciccone MM, Santobuono VE, Guaricci AI. Basile P, et al. J Clin Med. 2025 Mar 13;14(6):1951. doi: 10.3390/jcm14061951. J Clin Med. 2025. PMID: 40142759 Free PMC article.

Heart Rate Reduction and the Prognosis of Heart Failure Focused on Ivabradine.

Kiuchi S, Ikeda T. Kiuchi S, et al. J Clin Med. 2025 Feb 7;14(4):1074. doi: 10.3390/jcm14041074. J Clin Med. 2025. PMID: 40004605 Free PMC article. Review.

Page of 1

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 39578732

3 results

Results by year